APA Цитирование

Rogers, K. A., Huang, Y., Ruppert, A. S., Abruzzo, L. V., Andersen, B. L., Awan, F. T., . . . Byrd, J. C. (2020). Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia. J Clin Oncol.

Chicago-стиль цитирования

Rogers, Kerry A., et al. "Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia." J Clin Oncol 2020.

MLA-цитирование

Rogers, Kerry A., et al. "Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia." J Clin Oncol 2020.

Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.